Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia

Cited by papers we hold 4

• Advances and Limitations of Antibody Drug Conjugates for Cancer · 2021
  No notice
• How to select IgG subclasses in developing anti-tumor therapeutic antibodies · 2020
  No notice
• Myeloid-derived suppressor cells—new and exciting players in lung cancer · 2020
  No notice
• BCMA-targeted immunotherapy for multiple myeloma · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.